Physician
Mercy Health Physicians Cincinnati, LLC
Mercy Health Physicians Cincinnati, LLC was paid $28.01M by Medicaid between Jan 2018 and Dec 2024, across 264 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 46% of everything it billed.
33Billing provider infoMERCY HEALTH PHYSICIANS CINCINNATI, LLC
CINCINNATI, OH 45237
CINCINNATI, OH 45237
33aNPI1205887023assigned 05/15/2006
33bProvider typeInternal Medicine Physician
28Total paid$28.01M
24GClaims2,240,435
24DCodes billed264
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Ohio
Rank by total paid#1 of 663
Median peer was paid$17K
This provider vs. median1,608×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 456,421 | $5.08M | |
| 2019 | 428,676 | $5.53M | |
| 2020 | 410,128 | $5.06M | |
| 2021 | 417,445 | $5.18M | |
| 2022 | 208,672 | $2.72M | |
| 2023 | 187,884 | $2.49M | |
| 2024incomplete | 131,209 | $1.96M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 46% | 256,715 | 237,954 | $12.93M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 183,028 | 168,391 | $6.43M |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2.8% | 127,427 | 108,359 | $790K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 2.5% | 25,259 | 11,925 | $713K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.4% | 16,602 | 15,795 | $661K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.8% | 7,199 | 6,896 | $505K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.8% | 10,659 | 10,244 | $496K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.6% | 31,303 | 14,279 | $456K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.4% | 21,485 | 10,272 | $389K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.3% | 10,126 | 7,495 | $372K |
| 99223 | Prolong inpt eval add15 m | <1% | 5,178 | 4,773 | $259K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 5,172 | 1,960 | $222K |
252 more codes
| 99255 | <1% | 2,475 | $221K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 3,234 | $186K |
| 20610 | <1% | 5,242 | $176K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,626 | $168K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 2,480 | $149K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 11,713 | $145K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,741 | $139K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,281 | $113K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 6,793 | $104K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,672 | $97K |
| 95811 | <1% | 1,434 | $89K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 2,528 | $88K |
| 90686 | <1% | 6,722 | $79K | |
| 95886 | <1% | 2,142 | $77K | |
| 90674 | <1% | 3,373 | $74K | |
| 99243 | <1% | 1,449 | $73K | |
| 93000 | <1% | 6,618 | $71K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 592 | $67K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,141 | $67K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,157 | $65K |
| 99205 | Prolong outpt/office vis | <1% | 612 | $58K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 742 | $58K |
| 0001A | <1% | 1,157 | $48K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 678 | $45K |
| 99385 | <1% | 629 | $45K | |
| 93971 | <1% | 2,801 | $43K | |
| 0002A | <1% | 1,045 | $40K | |
| 93016 | <1% | 2,472 | $36K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 17,279 | $33K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,947 | $33K |
| 43775 | <1% | 51 | $31K | |
| 0011A | <1% | 841 | $30K | |
| 64721 | <1% | 167 | $30K | |
| 73610 | <1% | 1,808 | $29K | |
| 0012A | <1% | 757 | $29K | |
| 93298 | <1% | 1,656 | $29K | |
| 95911 | <1% | 291 | $28K | |
| 93296 | <1% | 2,817 | $28K | |
| 95909 | <1% | 502 | $28K | |
| 99458 | <1% | 801 | $28K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 433 | $25K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 842 | $25K |
| 93970 | <1% | 1,020 | $25K | |
| 93018 | <1% | 2,825 | $24K | |
| 73630 | <1% | 1,517 | $23K | |
| 99454 | <1% | 905 | $23K | |
| 92557 | <1% | 898 | $22K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,847 | $21K |
| 99457 | <1% | 1,044 | $21K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 3,761 | $19K |
| 99254 | <1% | 276 | $18K | |
| 93295 | <1% | 557 | $16K | |
| L4360 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 111 | $16K |
| 93015 | <1% | 245 | $14K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 1,104 | $13K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 218 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,053 | $13K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,316 | $13K |
| 90670 | <1% | 1,857 | $12K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 311 | $12K |
| 31231 | <1% | 168 | $12K | |
| 93299 | <1% | 608 | $11K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,044 | $11K |
| 90837 | Psychotherapy session, about an hour | <1% | 129 | $11K |
| 64483 | <1% | 328 | $11K | |
| 90682 | <1% | 270 | $11K | |
| 73562 | <1% | 692 | $10K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 882 | $10K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 111 | $10K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 169 | $10K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 316 | $10K |
| 97597 | <1% | 1,756 | $9K | |
| 47562 | <1% | 25 | $9K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,074 | $9K |
| 99422 | <1% | 424 | $9K | |
| 99386 | <1% | 99 | $9K | |
| 99406 | <1% | 1,185 | $8K | |
| 99253 | <1% | 174 | $8K | |
| 92552 | <1% | 722 | $8K | |
| 73030 | <1% | 454 | $7K | |
| 90688 | <1% | 673 | $7K | |
| 99421 | <1% | 672 | $7K | |
| 99051 | <1% | 353 | $7K | |
| 99443 | <1% | 364 | $7K | |
| 73564 | <1% | 339 | $7K | |
| 96101 | <1% | 70 | $7K | |
| 90661 | <1% | 277 | $7K | |
| 92567 | <1% | 692 | $6K | |
| 90732 | <1% | 64 | $6K | |
| 99442 | <1% | 461 | $6K | |
| 20611 | <1% | 131 | $6K | |
| 99383 | <1% | 100 | $6K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 673 | $5K |
| 0004A | <1% | 57 | $5K | |
| 94060 | <1% | 432 | $5K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 153 | $5K |
| 90750 | <1% | 45 | $5K | |
| 93294 | <1% | 328 | $5K | |
| 73110 | <1% | 306 | $5K | |
| 0071A | <1% | 48 | $4K | |
| 99423 | <1% | 127 | $4K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 40 | $4K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 28 | $4K |
| 73130 | <1% | 292 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 73 | $4K |
| 72100 | <1% | 238 | $4K | |
| 17311 | <1% | 13 | $4K | |
| 82962 | <1% | 2,679 | $4K | |
| 0072A | <1% | 36 | $4K | |
| 90633 | <1% | 301 | $3K | |
| 99221 | <1% | 176 | $3K | |
| 90698 | <1% | 829 | $3K | |
| 99242 | <1% | 79 | $3K | |
| 93880 | <1% | 154 | $3K | |
| 95816 | <1% | 156 | $3K | |
| 93297 | <1% | 206 | $3K | |
| 81025 | <1% | 416 | $3K | |
| 90756 | <1% | 105 | $2K | |
| 31575 | <1% | 41 | $2K | |
| 99381 | <1% | 34 | $2K | |
| 95908 | <1% | 42 | $2K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 58 | $2K |
| 99173 | <1% | 961 | $2K | |
| 90715 | <1% | 72 | $2K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 122 | $2K |
| 92551 | <1% | 328 | $2K | |
| 94729 | <1% | 433 | $2K | |
| 97802 | <1% | 28 | $2K | |
| 83655 | <1% | 184 | $2K | |
| 96127 | <1% | 456 | $2K | |
| 99292 | <1% | 64 | $2K | |
| 85018 | <1% | 821 | $2K | |
| 99453 | <1% | 181 | $2K | |
| 0074A | <1% | 16 | $2K | |
| 73560 | <1% | 141 | $2K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 106 | $2K |
| 90685 | <1% | 300 | $2K | |
| 95910 | <1% | 38 | $2K | |
| 96160 | <1% | 488 | $1K | |
| 97803 | <1% | 30 | $1K | |
| 51725 | <1% | 12 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 103 | $1K |
| 43235 | <1% | 15 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 26 | $1K |
| 90694 | <1% | 19 | $1K | |
| 73502 | <1% | 89 | $1K | |
| 80061 | Lipid panel | <1% | 100 | $1K |
| 90653 | <1% | 23 | $1K | |
| 90648 | <1% | 114 | $1K | |
| 0031A | <1% | 36 | $1K | |
| 93923 | <1% | 75 | $986.85 | |
| 93272 | <1% | 47 | $936.35 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 48 | $934.03 |
| 99384 | <1% | 12 | $924.64 | |
| 31624 | <1% | 45 | $873.87 | |
| 94726 | <1% | 289 | $868.44 | |
| 64493 | <1% | 18 | $845.63 | |
| 20553 | <1% | 53 | $812.59 | |
| 11102 | <1% | 28 | $804.79 | |
| 92550 | <1% | 83 | $784.14 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 2,504 | $777.45 |
| 95885 | <1% | 27 | $768.03 | |
| 81002 | <1% | 339 | $748.52 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $746.25 |
| 94618 | <1% | 75 | $728.06 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 13 | $722.30 |
| 98926 | <1% | 40 | $699.87 | |
| 96161 | <1% | 312 | $681.27 | |
| 87428 | <1% | 20 | $640.74 | |
| 90677 | <1% | 13 | $625.88 | |
| 64494 | <1% | 32 | $606.93 | |
| 20550 | <1% | 18 | $538.49 | |
| 72040 | <1% | 27 | $507.41 | |
| S9470 | Nutritional counseling, dietitian visit | <1% | 24 | $501.80 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 45 | $495.33 |
| 31645 | <1% | 14 | $474.94 | |
| 95806 | <1% | 52 | $434.39 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 229,142 | $431.42 |
| 90630 | <1% | 20 | $405.84 | |
| 90680 | <1% | 422 | $400.00 | |
| 90744 | <1% | 157 | $338.50 | |
| 93017 | <1% | 13 | $317.44 | |
| 95819 | <1% | 15 | $300.80 | |
| 99441 | <1% | 39 | $291.32 | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 29 | $286.43 |
| 93280 | <1% | 14 | $265.92 | |
| 93228 | <1% | 12 | $248.71 | |
| 90651 | <1% | 12 | $233.75 | |
| 99401 | <1% | 21 | $220.16 | |
| 90710 | <1% | 84 | $210.00 | |
| 90687 | <1% | 34 | $182.22 | |
| 93270 | <1% | 26 | $181.46 | |
| 94727 | <1% | 50 | $164.93 | |
| 82274 | <1% | 15 | $159.42 | |
| 99152 | <1% | 29 | $139.06 | |
| 96156 | <1% | 44 | $112.25 | |
| 11045 | <1% | 21 | $111.43 | |
| 99188 | <1% | 29 | $109.08 | |
| 92568 | <1% | 13 | $94.35 | |
| 90723 | <1% | 12 | $92.50 | |
| 99318 | <1% | 46 | $68.10 | |
| 90681 | <1% | 13 | $62.50 | |
| 81003 | <1% | 33 | $57.06 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 77 | $53.00 |
| L4361 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf | <1% | 13 | $51.41 |
| G8482 | Influenza immunization administered or previously received | <1% | 30,299 | $50.84 |
| G0008 | Administration of influenza virus vaccine | <1% | 130 | $41.82 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 431,651 | $41.32 |
| 90700 | <1% | 13 | $30.00 | |
| 76937 | <1% | 14 | $29.78 | |
| 1036F | <1% | 229,932 | $25.00 | |
| 91300 | <1% | 2,282 | $21.73 | |
| 90461 | <1% | 232 | $21.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 12,618 | $16.61 |
| 3017F | <1% | 104,803 | $16.61 | |
| 4004F | <1% | 58,514 | $16.61 | |
| 91301 | <1% | 1,607 | $15.34 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 12 | $12.30 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 12 | $11.75 |
| 90734 | <1% | 16 | $10.00 | |
| 91307 | <1% | 78 | $0.65 | |
| 91303 | <1% | 36 | $0.31 | |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 12,967 | $0.00 |
| 3075F | 0% | 764 | $0.00 | |
| G8926 | Spirometry test not performed or documented, reason not given | 0% | 4,247 | $0.00 |
| 1123F | 0% | 3,423 | $0.00 | |
| 3014F | 0% | 1,063 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 9,919 | $0.00 |
| 3074F | 0% | 7,185 | $0.00 | |
| 3044F | 0% | 240 | $0.00 | |
| 3079F | 0% | 1,740 | $0.00 | |
| 99024 | 0% | 375 | $0.00 | |
| 1101F | 0% | 266 | $0.00 | |
| 3080F | 0% | 17 | $0.00 | |
| 1111F | 0% | 247 | $0.00 | |
| 3052F | 0% | 13 | $0.00 | |
| 4040F | 0% | 2,319 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 195,770 | $0.00 |
| 3078F | 0% | 6,471 | $0.00 | |
| 3023F | 0% | 4,538 | $0.00 | |
| 2022F | 0% | 10,558 | $0.00 | |
| G8400 | Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given | 0% | 570 | $0.00 |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 2,478 | $0.00 |
| 3046F | 0% | 1,710 | $0.00 | |
| G8421 | Bmi not documented and no reason is given | 0% | 740 | $0.00 |
| 1090F | 0% | 1,300 | $0.00 | |
| 3045F | 0% | 190 | $0.00 | |
| 3077F | 0% | 175 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 45 | $0.00 |
| 0502F | 0% | 71 | $0.00 | |
| G8399 | Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed | 0% | 12 | $0.00 |
| 90671 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARDY, SHANE (CFO, MEDICAL GROUP)
| Provider | Location | Paid |
|---|---|---|
| Mercy Health Physicians Kentucky LLC | Paducah, KY | $11.90M |
| Bon Secours Medical Group Hampton Roads Specialty Care LLC | Richmond, VA | $9.80M |
| Mercy Health Physicians Cincinnati Specialty Care LLC | Cincinnati, OH | $7.18M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.